日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MeMAGEN: A Phase IIa/IIb open-label trial of memantine testing safety and tolerability in sickle cell patients

MeMAGEN:一项评估美金刚在镰状细胞病患者中安全性和耐受性的IIa/IIb期开放标签试验

Koren, Ariel; Levin, Carina; Livshits, Leonid; Valeri, Fabio; Peretz, Sari; Raz, Sivan; Bogdanova, Anna Yu; Gassmann, Max

MAGI3 deficiency unleashes β-catenin conformational change to drive metastatic progression and mTOR inhibitor resistance in ccRCC

MAGI3 缺陷引发 β-catenin 构象变化,从而驱动 ccRCC 的转移进展和 mTOR 抑制剂耐药性。

Gu, Siyu; Wang, Haibo; Liu, Hua; Yang, Yumeng; Guo, Yu; Fa, Pengyan; Zhang, Lijie; Yang, Yang; Qi, Xuan; Qin, Qiong; Song, Ran; Yang, Xiaomei; He, Junqi

Epigenetic and fragment-based profiling across CDK4/6 inhibitors in first-line HR+/HER2- metastatic breast cancer. An ancillary analysis of the MAGNETIC.1 study

针对一线 HR+/HER2- 转移性乳腺癌,对 CDK4/6 抑制剂进行表观遗传学和片段分析。MAGNETIC.1 研究的辅助分析

Noto, Claudia; Foffano, Lorenzo; Giudici, Fabiola; Molteni, Elisabetta; Franzoni, Alessandra; Tessitori, Martina; Cucciniello, Linda; Bolzonello, Silvia; Da Ros, Lucia; Bortot, Lucia; Scudeler, Elena; Pastò, Brenno; Cudia, Giulia; Della Rossa, Serena; Bonotto, Marta; Minisini, Alessandro Marco; Damante, Giuseppe; Belletti, Barbara; Gerratana, Lorenzo; Puglisi, Fabio

Evaluation of end-to-end 3D absorbed dose distribution in (90)Y-SIRT and SBRT combination therapy using MAGIC-f polymer gel dosimeter

使用 MAGIC-f 聚合物凝胶剂量计评估 (90)Y-SIRT 和 SBRT 联合治疗中端到端 3D 吸收剂量分布

Mansouri, Zahra; Salimi, Yazdan; Koutsouvelis, Nikolaos; Zaidi, Habib

FAAH and MAGL inhibition: Evolving approaches to treating substance use disorders

FAAH 和 MAGL 抑制:物质使用障碍治疗的不断发展的方法

Maddox, Charlie J; Lee, Francis S; Rajadhyaksha, Anjali M; Martínez-Rivera, Arlene

A genome-wide MAGIC kit for recombinase-independent mosaic analysis in Drosophila

用于果蝇基因组范围内重组酶非依赖性嵌合体分析的MAGIC试剂盒

Shen, Yifan; Yeung, Ann T; Ditchfield, Payton; Korn, Elizabeth; Clements, Rhiannon; Chen, Xinchen; Wang, Bei; Huang, Zixian; Sheen, Michael; Jarman, Parker A; Han, Chun

YTHDC1-Mediated m(6)A Modification of MAGI3 mRNA Regulates Proliferation and Differentiation of Myoblasts.

YTHDC1介导的MAGI3 mRNA的m(6)A修饰调节成肌细胞的增殖和分化。

Chen Qian, He Siqi, Xue Xianglan, Zhang Wen, Li Hurong, He Xiaohong, Pu Yabin, Ma Yuehui, Jiang Lin, Zhao Yanhong, Zhao Qianjun

Shiny-MAGEC: A Bayesian R shiny application for meta-analysis of censored adverse events

Shiny-MAGEC:用于对删失不良事件进行荟萃分析的贝叶斯 R Shiny 应用程序

Zhou, Zihan; Tian, Zizhong; Peterson, Christine; Bao, Le; Zhou, Shouhao

Case Report: Novel MAGT1 pathogenic variant with significant atopy, hypogammaglobulinemia and viral skin infections

病例报告:一种新型 MAGT1 致病变异体,伴有显著的特应性皮炎、低丙种球蛋白血症和病毒性皮肤感染

Gunderman, Lauren; Ptak, Christopher P; Schutt, Madeline; Yahashiri, Kento; Lippner, Elizabeth; Khojah, Amer; Ahmed, Aisha; Khanolkar, Aaruni

MAGL-18c attenuates LPS-induced sepsis-associated liver injury by inhibiting TGF-β/Smad signaling and remodeling medium- and long-chain fatty acid metabolism

MAGL-18c通过抑制TGF-β/Smad信号通路和重塑中长链脂肪酸代谢,减轻LPS诱导的脓毒症相关肝损伤。

Wang, Ying; Li, Meijia; Liang, Zixia; Wang, Yunyu; Li, Honghua; Li, Shirong; Jiao, Xu; Guo, Na; Dai, Guoxin; Zhang, Guimin; Lu, Xiaoyan; Yao, Jingchun